Publications by authors named "Lina Jeantin"

Article Synopsis
  • Sleep disorders like insomnia and hypersomnia were observed in a patient with anti-NMDAr encephalitis related to an ovarian teratoma.
  • Despite initial improvement with immunotherapy, the patient’s condition worsened, revealing severe sleep issues through a 24-hour EEG-polysomnography study.
  • Following additional immunotherapy and surgery to remove the teratoma, the patient's clinical symptoms and sleep patterns significantly improved, highlighting the need for more research on sleep in this condition.
View Article and Find Full Text PDF

Background: Fungal infections of the central nervous system usually affect immunocompromised patients. Primary myelitis has never been described.

Report: A 45-year-old immunocompetent male with subacute paraplegia was treated for inflammatory myelitis before clinical deterioration requiring mechanical ventilation.

View Article and Find Full Text PDF

Background: Epidemiologic studies on coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (pwMS) have focused on the first waves of the pandemic until early 2021.

Objectives: We aimed to extend these data from the onset of the pandemic to the global coverage by vaccination in summer 2022.

Methods: This retrospective, multicenter observational study analyzed COVISEP registry data on reported COVID-19 cases in pwMS between January 2020 and July 2022.

View Article and Find Full Text PDF

Background And Purpose: Despite their detrimental impact on the quality of life in autoimmune encephalitis, sleep disorders have not been investigated in anti-glutamic acid decarboxylase (GAD65) associated neurological syndromes.

Methods: Six consecutive adult patients diagnosed with anti-GAD65-associated neurological syndromes (four with limbic encephalitis and two with stiff-person syndrome) and 12 healthy controls were enrolled. Participants underwent sleep interviews and sleep studies including night-time video-polysomnography, followed by five daytime multiple sleep latency tests (MSLTs, to assess propensity to fall asleep) and an 18 h bed rest polysomnography (to assess excessive sleep need).

View Article and Find Full Text PDF

Sepsis-associated encephalopathy is a severe neurologic syndrome characterized by a diffuse dysfunction of the brain caused by sepsis. This review provides a concise overview of diagnostic tools and management strategies for SAE at the acute phase and in the long term. Early recognition and diagnosis of SAE are crucial for effective management.

View Article and Find Full Text PDF

Background: Although vaccination against SARS-CoV-2 is recommended prior to introducing anti-CD20 therapies, limited data are available regarding the evolution of post-vaccinal immunity.

Methods: This retrospective study compared anti-Spike antibody titres at 6 and 12 months from SARS-CoV-2 vaccination between patients vaccinated before switching to anti-CD20 ('Switch') and two control groups: (1) patients vaccinated under disease-modifying therapies (DMTs) other than fingolimod and anti-CD20 ('Other DMTs'); (2) patients vaccinated on anti-CD20 ('Anti-CD20'). Anti-Spike-specific T-cell responses were compared between 'Switch' and 'Anti-CD20' groups.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the vaccine response in multiple sclerosis (MS) patients treated with anti-CD20, specifically looking at the effects of an enhanced BNT162b2 vaccine regimen on their immune response to SARS-CoV-2.
  • Results showed that patients on anti-CD20 had significantly lower seropositivity and neutralization activity after vaccination compared to those on other MS treatments, especially against the Omicron variant.
  • A delayed booster vaccination did improve seropositivity in anti-CD20 patients, but their neutralizing response remained notably weak compared to patients receiving other therapies.
View Article and Find Full Text PDF

Background: Natalizumab is a high-efficacy therapy for recurrent multiple sclerosis (RMS) with a four-week administration interval. Controlled trials have shown that extending this interval to six weeks led to better safety without increasing the risk of relapse. We aimed to analyze the safety of extending the natalizumab interdose interval from 4 to 6 weeks in a real-life setting.

View Article and Find Full Text PDF

Background: Electroencephalography (EEG) is recommended for the practical approach to the diagnosis and prognosis of encephalitis. We aimed to investigate the prognostic value of standard EEG (EEG) in adult patients with severe herpes simplex encephalitis.

Methods: We performed a retrospective analysis of consecutive ICU patients with severe herpes simplex encephalitis in 38 French centers between 2006 and 2016.

View Article and Find Full Text PDF

Objective: While myocardial impairment is a predictor of poor prognosis in antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), little is known about valvular involvement. This study aims at describing the clinical presentation, management, and outcome of endocarditis associated with AAV.

Methods: We conducted a multicenter retrospective study in centers affiliated with the French Vasculitis Study Group.

View Article and Find Full Text PDF

spp. myelopathies are very rare. We report a case of subacute longitudinally extensive transverse myelitis in an apparently immunocompetent 55-year-old man.

View Article and Find Full Text PDF